Journals / Uluslararası Akademi Dergisi / 2024 / Cilt: 3 - Sayı: 1

Memory Functionality and Mental Health in Multiple Sclerosis

Multipl Sklerozda Bellek İşlevselliği ve Ruh Sağlığı

Pages
14–22
Publication Date
2024-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result of the cognitive evaluation, it was found that individuals diagnosed with Multiple Sclerosis scored lower in all sub-scores of the Selective Recall Test, 10/36 Spatial Recall Test and Digit Span Tests compared to the control group, and this difference was statistically significant.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of the study is to evaluate the memory functions and symptoms of mental disorders in patients diagnosed with Multiple Sclerosis and to compare them with healthy individuals. 100 individuals diagnosed with Multiple Sclerosis and 60 individuals not diagnosed with Multiple Sclerosis voluntarily participated in the study.
📊
Key Findings & Data:In order to evaluate the memory functions of individuals, the Selective Recall Test, 10/36 Spatial Recall Test and Digit SpanTest tasks were applied.
💡
Conclusion & Impact:As a result of the cognitive evaluation, it was found that individuals diagnosed with Multiple Sclerosis scored lower in all sub-scores of the Selective Recall Test, 10/36 Spatial Recall Test and Digit Span Tests compared to the control group, and this difference was statistically significant.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Multipl Skleroz · Bellek · Ruh Sağlığı

Abstract

The aim of the study is to evaluate the memory functions and symptoms of mental disorders in patients diagnosed with Multiple Sclerosis and to compare them with healthy individuals. 100 individuals diagnosed with Multiple Sclerosis and 60 individuals not diagnosed with Multiple Sclerosis voluntarily participated in the study. In order to evaluate the memory functions of individuals, the Selective Recall Test, 10/36 Spatial Recall Test and Digit SpanTest tasks were applied. The Depression, Anxiety and Stress Scale-21 was used to evaluate the symptoms of mental disorders. As a result of the cognitive evaluation, it was found that individuals diagnosed with Multiple Sclerosis scored lower in all sub-scores of the Selective Recall Test, 10/36 Spatial Recall Test and Digit Span Tests compared to the control group, and this difference was statistically significant. In the evaluation of mental health, the group diagnosed with Multiple Sclerosis had higher depression, anxiety and stress levels compared to the control group, and there was a statistically significant difference between the two groups. It was found that being diagnosed with Multiple Sclerosis was associated with poor memory performance and higher symptoms of mental disorders. The findings of the study support the findings of the studies conducted in the field.

Özet

Çalışmanın amacı, Multipl Skleroz tanısı alan hastaların bellek işlevselliğinin ve ruhsal bozukluk semptomlarının değerlendirilmesi ve sağlıklı bireyler ile karşılaştırılmasıdır. Araştırmaya 100 MS’li birey ve 60 Multipl Skleroz tanısı almayan sağlıklı birey gönüllü olarak katılmıştır. Bireylerin bellek işlevlerinin değerlendirilmesi amacıyla Seçici Hatırlama Testi, 10/36 Uzamsal Bellek Testi ve Sayı Dizisi Testi görevleri uygulanmıştır. Ruhsal bozukluk semptomlarının değerlendirilmesi amacıyla ise Depresyon, Anksiyete, Stres Ölçeği-21 kullanılmıştır. Yapılan bilişsel değerlendirme sonucu, Multipl Skleroz tanısı alan bireylerin Seçici Hatırlama Testi, 10/36 Uzamsal Bellek Testi ve Sayı Dizisi testlerinin tüm alt puanlamalarından kontrol grubuna göre daha düşük puan aldığı ve bu farkın istatistiksel olarak anlamlı olduğu görülmektedir. Ruh sağlığı değerlendirilmesinde ise Multipl Skleroz tanısı alan grubun kontrol grubuna kıyasla depresyon, anksiyete ve stres düzeylerinin daha yüksek olduğu ve iki grup arasında istatistiksel olarak anlamlı bir fark olduğu mevcuttur. Multipl Skleroz tanısına sahip olmanın düşük bellek performansı ve yüksek ruhsal bozukluk semptomlarıyla ilişkili olduğu bulunmuştur. Çalışmanın bulguları, alanda yapılan çalışma bulgularını desteklemektedir.

🔖

Cite This Article

DÜNDAR, A. H. (2024). Memory Functionality and Mental Health in Multiple Sclerosis. Uluslararası Akademi Dergisi, Cilt: 3 - Sayı: 1, 14–22. https://ajindex.com/articles/1023120

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Amato, M. P., Langdon, D., Montalban, X., Benedict, R. H., DeLuca, J., Krupp, L. B., Thompson, A. J. & Comi, G. (2013). Treatment of cognitive impairment in multiple sclerosis: Position paper. Journal of Neurology, 260(6), 1452-68.
  2. Amato, M. P., Portaccio, E., Goretti, B., Zipoli, V., Iudice, A., Pina, D. D., Malentacchi, G., Sabatini, S., Annunziata, P., Falcini, M., Mazzoni, M., Mortilla, M., Fonda, C. & De Stefano, N. (2010). Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Multiple Sclerosis Journal, 16(12), 1474-1482.
  3. Benedict, R. H., Cookfair, D., Gavett, R., Gunther, M., Munschauer, F., Garg, N. & Weinstock-Guttman, B. (2006). Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). Journal of the International Neuropsychological Society, 12(4), 549-58.
  4. Bilgi, E., Özdemir, H. H. & Bulut, S. (2013). Determining the Frequency of Depression and Cognitive Dysfunction in Patients with Multiple Sclerosis. Turkish Journal of Neurology, 19, 11-4.
  5. Boeschoten, R. E., Braamse, A. M., Beekman, A. T., Cuijpers, P., Van Oppen, P., Dekker, J. & Uitdehaag, B. M. J. (2017). Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences, 372, 331-341.
  6. Borghi, M., Carletto, S., Ostacoli, L., Scavelli, F., Pia, L., Pagani, M., Bertolotto, A., Malucchi, S., Signori, A. & Cavallo, M. (2016). Decline of neuropsychological abilities in a large sample of patients with multiple sclerosis: A two-year longitudinal study. Frontiers in Human Neuroscience, 10, 282. Boringa, J. B., Lazeron, R. H., Reuling, I. E., Ader, H. J., Pfennings, L. E., Lindeboom, J., De Sonneville, L. MJ., Kalkes, N. F. & Polman, C. H. (2001). The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Multiple Sclerosis Journal, 7, 263-267.
  7. Campbell, J., Rashid, W., Cercignani, M. & Langdon, D. (2016). Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life. Postgraduate Medical Journal, 1-5.
  8. Chiaravalloti, N. D. & DeLuca, J. (2008). Cognitive impairment in multiple sclerosis. The lancet. Neurology, 7(12), 1139. Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. & Kraft, G.H. (2002). Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. The American Jo